Pages that link to "Q22254649"
Jump to navigation
Jump to search
The following pages link to Isolation and characterization of two novel phosphodiesterase PDE11A variants showing unique structure and tissue-specific expression (Q22254649):
Displaying 50 items.
- Phosphodiesterase 11A (Q21119704) (← links)
- Binding of cyclic nucleotides to phosphodiesterase 10A and 11A GAF domains does not stimulate catalytic activity (Q24336415) (← links)
- Cloning and characterization of two splice variants of human phosphodiesterase 11A (Q24676977) (← links)
- A short review on structure and role of cyclic-3',5'-adenosine monophosphate-specific phosphodiesterase 4 as a treatment tool (Q26773564) (← links)
- The pleiotropic effects of phosphodiesterase 5 inhibitors on function and safety in patients with cardiovascular disease and hypertension (Q26852171) (← links)
- RNA splicing in regulation of nitric oxide receptor soluble guanylyl cyclase (Q27001569) (← links)
- Alterations of Phosphodiesterases in Adrenocortical Tumors (Q28066278) (← links)
- The human phosphodiesterase PDE10A gene genomic organization and evolutionary relatedness with other PDEs containing GAF domains (Q28116175) (← links)
- Genomic organization of the human phosphodiesterase PDE11A gene. Evolutionary relatedness with other PDEs containing GAF domains (Q28140572) (← links)
- Comparison of enzymatic characterization and gene organization of cyclic nucleotide phosphodiesterase 8 family in humans (Q28189284) (← links)
- Identification of rat cyclic nucleotide phosphodiesterase 11A (PDE11A): comparison of rat and human PDE11A splicing variants (Q28212447) (← links)
- 3',5'-cyclic nucleotide phosphodiesterase 11A: localization in human tissues (Q28242677) (← links)
- A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia (Q28245373) (← links)
- Expression of PDE11A in normal and malignant human tissues (Q28259848) (← links)
- cAMP is a ligand for the tandem GAF domain of human phosphodiesterase 10 and cGMP for the tandem GAF domain of phosphodiesterase 11 (Q28285255) (← links)
- High biochemical selectivity of tadalafil, sildenafil and vardenafil for human phosphodiesterase 5A1 (PDE5) over PDE11A4 suggests the absence of PDE11A4 cross-reaction in patients (Q28292736) (← links)
- Silencing, positive selection and parallel evolution: busy history of primate cytochromes C (Q28392800) (← links)
- Phosphodiesterase 10A Is Tethered to a Synaptic Signaling Complex in Striatum (Q28393596) (← links)
- Subcellular localization of cyclic nucleotide phosphodiesterase type 10A variants, and alteration of the localization by cAMP-dependent protein kinase-dependent phosphorylation (Q28564202) (← links)
- Novel alternative splice variants of rat phosphodiesterase 7B showing unique tissue-specific expression and phosphorylation (Q28569506) (← links)
- cGMP-phosphodiesterase activity is up-regulated in response to pressure overload of rat ventricles (Q28570251) (← links)
- PfPDE1, a novel cGMP-specific phosphodiesterase from the human malaria parasite Plasmodium falciparum (Q30045366) (← links)
- Phosphodiesterase 11A in brain is enriched in ventral hippocampus and deletion causes psychiatric disease-related phenotypes. (Q30478804) (← links)
- Intracellular localization of 7-benzylamino-6-chloro-2-piperazino-4-pyrrolidino-pteridine in membrane structures impeding the inhibition of cytosolic cyclic AMP-specific phosphodiesterase (Q30704013) (← links)
- Sudachitin, a polymethoxyflavone from Citrus sudachi, suppresses lipopolysaccharide-induced inflammatory responses in mouse macrophage-like RAW264 cells (Q34031267) (← links)
- Human phosphodiesterase 8A splice variants: cloning, gene organization, and tissue distribution (Q34104505) (← links)
- Identification and distribution of different mRNA variants produced by differential splicing in the human phosphodiesterase 9A gene (Q34174785) (← links)
- PDE4 cAMP-specific phosphodiesterases (Q34364468) (← links)
- Novel drug targets for the pharmacotherapy of benign prostatic hyperplasia (BPH). (Q35089850) (← links)
- Current and future trends in the oral pharmacotherapy of male erectile dysfunction (Q35207625) (← links)
- Activation of PDE10 and PDE11 phosphodiesterases (Q35668878) (← links)
- Promoter methylation of candidate genes associated with familial testicular cancer (Q36282511) (← links)
- Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies (Q36334968) (← links)
- Phosphodiesterase 11: a brief review of structure, expression and function (Q36361603) (← links)
- Phosphodiesterase function and endocrine cells: links to human disease and roles in tumor development and treatment (Q36503940) (← links)
- Phosphodiesterases and adrenal Cushing in mice and humans (Q36514530) (← links)
- Intracellular targeting of phosphodiesterase-4 underpins compartmentalized cAMP signaling (Q36597940) (← links)
- A cAMP-specific phosphodiesterase (PDE8B) that is mutated in adrenal hyperplasia is expressed widely in human and mouse tissues: a novel PDE8B isoform in human adrenal cortex (Q37163859) (← links)
- Phosphodiesterase 11A expression in the adrenal cortex, primary pigmented nodular adrenocortical disease, and other corticotropin-independent lesions. (Q37267926) (← links)
- Phosphodiesterase genes and antidepressant treatment response: a review (Q37302885) (← links)
- Phosphodiesterase 11A (PDE11A), Enriched in Ventral Hippocampus Neurons, is Required for Consolidation of Social but not Nonsocial Memories in Mice. (Q37335108) (← links)
- Interactions between cyclic nucleotide phosphodiesterase 11 catalytic site and substrates or tadalafil and role of a critical Gln-869 hydrogen bond (Q37397220) (← links)
- Clinical and molecular genetics of the phosphodiesterases (PDEs). (Q37657841) (← links)
- Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments (Q37947681) (← links)
- Effectiveness and safety of phosphodiesterase 5 inhibitors in patients with cardiovascular disease and hypertension (Q38126803) (← links)
- Effect of the phosphodiesterase 4 inhibitor, rolipram, on retinoic acid-increased alkaline phosphatase activity in the mouse fibroblastic C3H10T1/2 cell line (Q40666938) (← links)
- 7-Benzylamino-6-chloro-2-piperazino-4-pyrrolidino-pteridine, a potent inhibitor of cAMP-specific phosphodiesterase, enhancing nuclear protein binding to the CRE consensus sequence in human tumour cells (Q40734160) (← links)
- Association of PDE11A global haplotype with major depression and antidepressant drug response. (Q41528335) (← links)
- Expression and distribution of key enzymes of the cyclic GMP signaling in the human clitoris: relation to phosphodiesterase type 5 (PDE5). (Q42490401) (← links)
- PDE11A regulates social behaviors and is a key mechanism by which social experience sculpts the brain. (Q42533982) (← links)